Mitochondrial damage contribute to epigallocatechin-3-gallate induced death in Leishmania amazonensis  by Inacio, Job D.F. et al.
Experimental Parasitology 132 (2012) 151–155Contents lists available at SciVerse ScienceDirect
Experimental Parasitology
journal homepage: www.elsevier .com/locate /yexprMitochondrial damage contribute to epigallocatechin-3-gallate induced death in
Leishmania amazonensis
Job D. F. Inacio a, Marilene M. Canto-Cavalheiro a, Rubem F. S. Menna-Barreto b, Elmo E. Almeida-Amaral a,⇑
a Laboratório de Bioquímica de Tripanosomatideos, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Rio de Janeiro, Brazil
b Laboratório de Biologia Celular, IOC, FIOCRUZ, Rio de Janeiro, Rio de Janeiro, Brazilh i g h l i g h t s
" EGCG induced mitochondrial
collapse in Leishmania amazonensis
promastigotes.
" EGCG inhibited the cellular
proliferation in a time and dose-
dependent manner.
" EGCG-treated promastigotes showed
ultrastructural alteration of the
mitochondria.0014-4894  2012 Elsevier Inc. Open access under the El
http://dx.doi.org/10.1016/j.exppara.2012.06.008
⇑ Corresponding author. Address: Laboratório de Bioq
IOC/FIOCRUZ, Pavilhão Leônidas Deane, 4 andar, sala
Rio de Janeiro, RJ, Brazil.
E-mail address: elmo@ioc.ﬁocruz.br (E.E. Almeida-g r a p h i c a l a b s t r a c ta r t i c l e i n f o
Article history:
Received 17 February 2012
Received in revised form 15 June 2012
Accepted 17 June 2012
Available online 23 June 2012
Keywords:
Mitochondrial collapse
Mitochondrial membrane potential (Dwm)
Epigallocatechin-3-gallate
Mitochondria
Flavonoid
Leishmania amazonensisa b s t r a c t
Epigallocatechin-3-gallate (EGCG), the most abundant ﬂavonoid in green tea, has been reported to have
antiproliferative effects on Trypanosoma cruzi however, the mechanism of protozoan action of EGCG has
not been studied. In the present study, we demonstrate the mechanism for the antileishmanial activity of
EGCG against Leishmania amazonensis promastigotes. Incubation with EGCG signiﬁcantly inhibited L.
amazonensis promastigote proliferation in a time- and dose-dependent manner. The IC50 for EGCG at
120 h was 0.063 mM. Ultrastructural alterations of the mitochondria were observed in promastigote trea-
ted with EGCG, being the organelle injury reinforced by the decrease in rhodamine 123 ﬂuorescence. The
effects of several drugs that interfere directly with mitochondrial physiology in parasites such as Leish-
mania have been described. The unique mitochondrial features of Leishmaniamake this organelle an ideal
drug target while minimizing toxicity. These data suggest mitochondrial collapse as a part of the EGCG
mechanism of action and demonstrate the leishmanicidal effect of EGCG.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
The effects of several drugs that interfere directly with mito-
chondrial physiology in parasites such as Leishmania have been de-
scribed (Rodrigues and de Souza, 2008; Sen and Majumder, 2008).
The mitochondria of Leishmania exhibit a unique structure and aresevier OA license. 
uímica de Tripanosomatideos,
405, Manguinhos, 21045-900
Amaral).functionally distinct from mammalian mitochondria, making this
organelle an exceptional chemotherapeutical target. Leishmania
has a single large mitochondrion which is distributed in branches
under the subpelicular microtubes and a specialized region rich
in DNA called the kinetoplast (de Souza et al., 2009).
Leishmaniasis, a parasitic disease caused by protozoa of the
genus Leishmania and presents extensive mortality and morbidity.
This disease is endemic in 88 countries, mainly in tropical and sub-
tropical areas and affects more than 12 million people worldwide.
(Chawla and Madhubala, 2010; Desjeux, 2004; Santos et al., 2008).
Leishmania amazonensis, originally described in the Amazon region,
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neous or diffuse cutaneous lesions but can also cause the complete
clinical spectrum of leishmaniasis, including visceral infection.
Treatment of leishmaniasis is currently based on pentavalent anti-
monials, and amphotericin B however, these drugs present serious
problems regarding side-effects, variable efﬁcacy and are expen-
sive (Amato et al., 2008l; Barral et al., 1991; Croft and Coombs,
2003; Grimaldi and Tesh, 1993).
Extracts obtained from plants and pure compounds have been
reported to possess signiﬁcant antiprotozoan activities with no
side effects (Asres et al., 2001; Fonseca-Silva et al., 2011; Mukher-
jee et al., 2009; Muzitano et al., 2006). Epigallocatechin-3-gallate
(EGCG) is the most abundant and biologically active compound
in green tea (Chen et al., 2003; Higdon and Frei, 2003; Yang
et al., 2002). Although, cancer-preventive activities (Khan et al.,
2006; Yang et al., 2002) and antiproliferative effects on Trypano-
soma cruzi (Guida et al., 2007) has been reported, the mechanism
of action has not been clearly establish.
In the present study, we evaluated the mechanism of EGCG
against promastigotes of L. amazonensis. Our results demonstrate
that the effect of the EGCG is associated with mitochondrial dys-
function, ultimately causing parasite death.Fig. 1. Effect of EGCG on L. amazonensis promastigotes proliferation. L. amazonensis
was cultivated in Schneider’s Drosophila medium at 26 C for 24–144 h in the
absence (closed circle) or presence of 0.065 mM (open circle), 0.125 mM (inverted2. Materials and methods
2.1. Reagents
Epigallocatechin-3-gallate, Schneider’s Drosophila medium, fe-
tal calf serum, and Rhodamine 123 were obtained from Sigma- Al-
drich (St Louis, MO, USA). Others reagents were purchased from
Merck (São Paulo, Brazil). Deionized distilled water was obtained
using a MilliQ system of resins (Millipore Corp., Bedford, MA,
USA) and was used in the preparation of all solutions. The EGCG
was prepared in Phosphate-buffered saline (PBS, pH 7.2).closed triangle) or 0.250 mM (open triangle) EGCG. The number of parasites was
determined by direct counting with a Neubauer chamber. In the control curve
(absence of EGCG), the same volume of PBS (solvent of EGCG) was added to the
growth medium. Values shown are the mean ± standard error of three different
experiments. ⁄⁄⁄p 6 0.001.2.2. Parasites
Promastigotes of L. amazonensis (MHOM/BR/LTB0016 strain)
were grown at 26 C in Schneider’s Drosophilamedium pH 7.2 sup-
plemented with 10% (v/v) heat-inactivated fetal calf serum. The
number of parasites was determined by direct counting with a
Neubauer chamber.Fig. 2. The reversibility of EGCG effect was tested after 120 h. L. amazonensis was
cultivated in Schneider’s Drosophila medium at 26 C for 120 h in the absence
(closed circle) or presence of 0.065 mM (open circle), 0.125 mM (inverted closed
triangle) or 0.250 mM (open triangle) EGCG, then promastigotes were washed with
PBS, seeded into fresh medium without EGCG for 24–120 h at 26 C. The number of
parasites was determined by direct counting with a Neubauer chamber Values
shown are the mean ± standard error of three different experiments. ⁄⁄p 6 0.01.2.3. Cell proliferation
L. amazonensis promastigotes (MHOM/BR/LTB0016 strain) were
seeded into fresh medium that contained Schneider’s Drosophila
medium (1.0 mL ﬁnal volume), supplemented with 10% (v/v)
heat-inactivated fetal calf serum, in either the absence (10 lL
PBS) or presence of different concentrations of EGCG (10 lL;
0.065–0.250 mM), and were maintained for 24–144 h at 26 C.
The cell density was estimated using a Neubauer chamber. The
growth curve was initiated with 1.0  106 cells/mL. The 50% inhib-
itory concentration (IC50) was determined by logarithimic regres-
sion analysis using GraphPrism 5. The reversibility of EGCG effect
was tested after 120 h. Promastigotes were washed with PBS,
seeded into freshmediumwithout EGCG that contained Schneider’s
Drosophila medium (1.0 mL ﬁnal volume), supplemented with 10%
(v/v) heat-inactivated fetal calf serum and were maintained for 24–
120 h at 26 C. The cell density was estimated using a Neubauer
chamber. The growth curve was initiated with 1.0  106 cells/mL.2.4. Transmission electron microscopy analysis
Promastigotes (5  106 cells/mL) were treated with ECGC
(0.065–0.250 mM solutions) for 120 h in Schneider medium at
26 C. After washing with PBS, the parasites were ﬁxed with 2.5%
glutaraldehyde in 0.1 M Na-cacodylate buffer (pH 7.2) at room
temperature for 40 min, and post-ﬁxed with a solution of 1% osmi-
num tetroxide, 0.8% potassium ferricyanide and 2.5 mM CaCl2 for
20 min. The cells were dehydrated in an acetone series and embed-
ded in a PolyBed 812 resin (Menna-Barreto et al., 2005). Ultrathin
sections were stained with uranyl acetate and lead citrate and
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(Tokyo, Japan).2.5. Leishmania mitochondrial membrane potential (Dwm)
Promastigotes were treated for 120 h in the absence or in the
presence of EGCG (0.065–0.250 mM). Cells were harvested, resus-
pended in PBS and the cell number was counted in a Neubauer
chamber. Promastigotes (5  106 cells/mL) were incubated with
10 lg/ml rhodamine 123 for 20 min. Samples were kept on ice un-
til analysis. Data acquisition and analysis were performed using a
FACSCalibur ﬂow cytometer (Becton Dickinson, Franklin Lakes,
USA) equipped with the Cell Quest software (Joseph Trotter,
Scripps Research Institute, La Jolla, USA) as described (Fonseca-Sil-
va et al., 2011). A total of 10,000 events were acquired in the regionFig. 3. Ultrastructural alterations in L. amazonensis promastigotes promoted by EGCG. U
kinetoplast (K), mitochondria (M), ﬂagella (F) and nucleus (N). Promastigotes treated wi
revealed an intense cytoplasmic vacuolization (stars) and a remarkable swelling (aste
organelle (arrowheads). Maintenance of the classic kDNA arrangement (arrows) was alspreviously established as corresponding to the parasites. Altera-
tions in the ﬂuorescence for rhodamine 123 were quantiﬁed using
an index of variation (IV) obtained by the equation (MT – MC)/MC,
where MT is the median of ﬂuorescence for treated parasites and
MC is the median of control parasites. Negative IV values corre-
spond to depolarization of the mitochondrial membrane. Viability
was not affected under the conditions employed herein.2.6. Statistical analysis
All experiments were performed in triplicate. The data were
analyzed statistically using Student’s t-test and analysis of variance
(ANOVA) followed by Bonferroni’s post-test using GraphPad Prism
5 (GraphPad Software, La Jolla, CA, USA). Results were consideredntreated parasite (panel a) presenting typical elongated morphology with normal
th 0.065 mM (panel b), 0.125 mM (panel c) and 0.250 mM (panel d and e) of EGCG
risks) of mitochondria, with the appearance of membranar structures inside the
o observed. All scale bars correspond to 1 lm.
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dard errors.3. Results
To determine the effects of EGCG on the cellular proliferation of
L. amazonensis, we incubated the parasites with different concen-
trations of EGCG (0.065–0.250 mM) for 24–144 h. A clear time-
and dose-dependent inhibition on cellular proliferation was ob-
served (p 6 0.001). Incubation with EGCG signiﬁcantly inhibited
L. amazonensis promastigotes proliferation after 96 h (p 6 0.001).
This inhibition was maintained for up to 144 h of incubation. The
IC50 for EGCG at 120 h was 0.063 mM. The proliferation was com-
pletely blocked by 0.250 mM EGCG (Fig. 1). In order to test the
reversibility of the effect promoted by EGCG, L. amazonensis was
incubated with EGCG (0.065, 0.125 or 0.250 mM) for 120 h under
the same conditions described in Fig. 1, then the promastigotes
were washed with PBS and seeded into Schneider’s Drosophila
fresh medium without EGCG. Fig. 2 demonstrates that the cellular
proliferation of L. amazonensis, which was incubated with EGCG,
was not similar to the control (p 6 0.01).
Transmission electron microscopy of EGCG-treated promastig-
otes (0.065, 0.125 and 0.250 mM) for 120 h (Fig. 3a–e) evidenced
an extensive swelling in the parasite mitochondria (Fig. 3b–e aster-
istic) and an intense cytoplasmic vacuolization (Fig. 3b–d star). The
inner mitochondrial membrane was severely damaged, with a
washed-out matrix appearance decreasing the matrix electron
density (Fig. 3b–e). In addition, the appearances of membranar
structures inside the organelle were observed (Fig. 3c and d arrow-
heads). Notably, the preservation of the kDNA network morphol-
ogy was observed, even after the treatment with the higher
concentration of EGCG (Fig. 3 arrow).
To conﬁrm that EGCG induces an alteration in the mitochondria,
we measured the mitochondrial membrane potential (Dwm) using
the ﬂuorescent probe rhodamine 123, which accumulates within
energized mitochondria in conjunction with ﬂow cytometry analy-
sis. Fig. 4 (panel a) shows that L. amazonensis promastigotes treated
with 0.065, 0.125 and 0.250 mM EGCG for 120 h decreased rhoda-
mine 123 ﬂuorescence and thus altered Dwm. Such decrease was
quantiﬁed by IV values. Promastigotes treated with 0.065, 0.125
and 0.250 mM EGCG presented IV values of 0.20, 0.30 and
0.40, respectively. A linear correlation (R2 = 0.9844) was observedFig. 4. Effect of treatment of EGCG on the mitochondrial membrane potential of Leishman
0.250 mM EGCG for 120 h led to the depolarization of the mitochondria measured by the
labeled with rhodamine 123 (10 lg/mL). Data acquisition and analysis were performed us
10,000 events were acquired in the regions previously established as those corresponding
of variation and inhibition of L. amazonensis growth by EGCG (R2 = 0.9844).between the alteration of IV and inhibition of L. amazonensis
growth by EGCG (Fig 4b).4. Discussion
Epigallocatechin-3-gallate (EGCG) is the most abundant and
widely studied ﬂavonoid. EGCG has generated considerable inter-
est as a pharmaceutical compound with a wide range of therapeu-
tic activities (Khan et al., 2006) and one such activity is exhibited
against T. cruzi (Guida et al., 2007). In the present study, we dem-
onstrate that EGCG exerts its antileishmanial effect on L. amazon-
ensis promastigotes affecting parasite mitochondrial function.
Treatment of promastigotes with EGCG resulted in a time- and
dose-dependent inhibition on cellular proliferation. Incubation
with EGCG signiﬁcantly inhibited L. amazonensis promastigotes
proliferation after 96 h. and this inhibition was maintained for up
to 144 h. These results demonstrate the antileishmanial activity
of EGCG against L. amazonensis. Similar activity of EGCG was ob-
served in epimastigote forms of T. Cruzi which demonstrated a
dose-dependent effect (Guida et al., 2007). Trypanocidal effect of
EGCG against amastigote and trypomastigotes have been reported
(Paveto et al., 2004).
Mitochondria are essential cellular organelles that play a central
role in energy metabolism and are critical for the survival of any
cell. The maintenance of mitochondrial membrane potential
(Dwm) is vital for this metabolic process as well as for cell survival
(de Souza et al., 2009; Mehta and Shaha, 2006). Studies have dem-
onstrated that variations in Dwm induced by drugs are associated
with cell survival in T. cruzi (Menna-Barreto et al., 2009; Mukherjee
et al., 2009), Leishmania donovani (Mehta and Shaha, 2006) and L.
amazonensis (Fonseca-Silva et al., 2011; Rodrigues et al., 2007).
To elucidate the mechanism of cell death induced by EGCG, we
chose to measure the mitochondrial membrane potential because
previous studies have shown that the single mitochondria of the
kinetoplastid parasite is a good indicator of cellular dysfunction
(Luque-Ortega et al., 2001; Mehta and Shaha, 2006; Menna-Barreto
et al., 2009).
Ultrastructural alteration of the mitochondria was observed in
promastigotes treated with EGCG. The mitochondrial damage
was conﬁrmed by a decrease in rhodamine 123 ﬂuorescence and,
consequently, an alteration of the Dwm. Therefore, we suggest that
EGCG exerts its antileishmanial effect on L. amazonensis promastig-
otes by affecting parasite mitochondrial function. The linearia amazonensis promastigote. The treatment of promastigotes with 0.065, 0.125 and
decrease in rhodamine 123 ﬂuorescence (panel a). Promastigotes were subsequently
ing a FACSCalibur ﬂow cytometer (equipped with the Cell Quest software). A total of
to each form of L. amazonensis. Panel b: Correlation between the alteration of index
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amazonensis growth by EGCG reinforces this hypothesis.
Mitochondria are responsible for respiration and oxidative
phosphorylation in eukaryotes, including trypanosomes, and they
provide ATP through respiratory-coupled oxidative phosphoryla-
tion (Affranchino et al., 1985). During oxidative phosphorylation,
electrons are moved thorough the mitochondrial respiratory chain,
and a proton gradient is established across the inner mitochondrial
membrane as the energy source for ATP production.
A decrease in rhodamine 123 ﬂuorescence intensity when L.
amazonensis was treated with different concentrations of EGCG
suggests increased proton permeability across the inner mitochon-
drial membrane with increasing EGCG. This could decrease ATP
synthesis and result in parasite death. Ultrastructural alteration
and Collapse ofDwmwere observed in L. amazonensis (Fonseca-Sil-
va et al., 2011; Khouri et al., 2010), Leishmania donovani. (Roy et al.,
2008; Sen et al., 2007, 2004) and T. cruzi (Menna-Barreto et al.,
2007, 2009; Santa-Rita et al., 2005) after treatment with different
drugs.
5. Conclusion
Taken together, these results demonstrate the leishmanicidal
effect of EGCG and suggest the involvement of the mitochondrial
collapse as a part of mechanism of action for EGCG and encourage
us to point out the EGCG as a possible candidate for the chemo-
therapy of leishmaniasis. Further studies are needed to determine
this effect on murine experimental model of leishmaniasis
infection.
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